Liver Transplant Success Boosting New Drug Discovery

Is liver transplant successful with the senolytic drugs? New drugs have been developed to prevent the deterioration of the liver during storage and transplantation.

An existing drug could protect donor livers from damage during the transplantation process and reduce complications that occur afterward, suggests a study published in Science Translational Medicine.

The drugs, called senolytics, have been developed to target a key mechanism related to cancer and heart conditions, but in studies with mice, researchers discovered it can also prevent the deterioration of a vital part of the liver during storage and transplantation.

Liver Transplantation - Facts, Contraindications, Procedure, Follow up, Complications & Prognosis
Liver transplantation is a surgical option for the treatment of liver failure where the diseased liver is replaced with a healthy one.

‘Senolytic drugs that preserve the biliary tract during liver transplantation, could reduce the risk of transplant failure.’

The senolytic drugs were found to protect the liver’s biliary tract, which drains waste from the liver. Failure of the biliary tract can cause a transplant to fail, resulting in the need for a new liver in nearly a quarter of these cases.

Liver transplants are currently the only curative option for patients with end-stage liver disease. More than 6,000 people a year receive a liver transplant in Europe with 600 of those in the UK.

Traditionally livers are kept in cold storage at 4 degrees Celsius before transplantation. Previous studies have shown that there is a deterioration in the biliary tract in the time between the liver being removed from the donor and transplanted into the recipient, but the reason for this has not been understood.

Fatty Liver Disease: A Growing Health Problem in India - Causes, Symptoms, Diagnosis, Treatment
Non alcoholic fatty liver disease (NAFLD) is the leading cause of liver dysfunction worldwide and is a rapidly growing health problem in India.

To study the biological effects of liver preservation before transplantation, researchers from the University of Edinburgh used mouse models to mimic the procurement of livers, cold storage, and transport.

The team found that during organ preservation, liver cells called cholangiocytes, which maintain the function of the biliary tract, were most susceptible to senescence, an irreversible sleeping state that causes the cells to stop growing. Cold storage made senescence worse, leading to less regeneration of this type of cell after transplant.

Increase in Operating Room Visits After Liver Transplants
To reduce operating room revisits it is advisable not to match an obese liver transplant recipient with an alcoholic donor.

When scientists gave the senolytic drugs, which block senescence to mice, before the liver removal procedure, the biliary tract persevered. When the drug was tested in the laboratory on human livers not suitable for transplant, the structure of the biliary tract was maintained.

Experts say this suggests the drug treatment could reduce the risk of transplant failure due to biliary tract damage. They caution, however, that the safety and efficacy of the drug still need to be tested in human clinical trials.

New Diagnostic Test Prevents Liver Transplant In Kids
A diagnostic test was identified to detect biliary atresia in children to avoid liver transplantation. This disease is the top cause of liver transplant in kids.

The team also discovered that despite being prone to cell death during cold storage, hepatocytes - the main type of liver cell involved in metabolism, detoxification, and protein production – can regenerate as they were not as susceptible to senescence.

The need for liver transplant does not match the number of donors of transplantable livers. Therefore, we need to increase the success rate of liver transplantation that improves the quality of life of transplant patients and save on the personal and financial costs associated with transplant failure.

Source-Eurekalert